UNIONDALE, NY / ACCESS Newswire / February 12, 2025 / With over two decades of professional experience, Melanie Delehanty ...
Given these compelling results, Creative Medical Technology plans to advance the development of AlloStem (CELZ-201) for the treatment of late-stage Type 2 Diabetes and explore other potential ...